Related Experiment Video
Updated: Jul 10, 2026
Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques
Published on: July 5, 2018
Crystallization and preliminary crystallographic analysis of recombinant human galectin-1
Stacy A Scott1, Ken Scott, Helen Blanchard
1Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland 4222, Australia.
Abstract:
Galectin-1 is considered to be a regulator protein as it is ubiquitously expressed throughout the adult body and is responsible for a broad range of cellular regulatory functions. Interest in galectin-1 from a drug-design perspective is founded on evidence of its overexpression by many cancers and its immunomodulatory properties. The development of galectin-1-specific inhibitors is a rational approach to the fight against cancer because although galectin-1 induces a plethora of effects, null mice appear normal. X-ray crystallographic structure determination will aid the structure-based design of galectin-1 inhibitors. Here, the crystallization and preliminary diffraction analysis of human galectin-1 crystals generated under six different conditions is reported. X-ray diffraction data enabled the assignment of unit-cell parameters for crystals grown under two conditions, one belongs to a tetragonal crystal system and the other was determined as monoclinic P2(1), representing two new crystal forms of human galectin-1.
Insights
Researchers crystallized human galectin-1, a protein overexpressed in cancers. This structural data aids the design of new cancer inhibitors targeting galectin-1, a key regulator protein.
Area of Science:
- Biochemistry
- Structural Biology
- Oncology
Background:
- Galectin-1 is a ubiquitously expressed regulator protein with significant roles in cellular functions.
- Overexpression of galectin-1 in various cancers and its immunomodulatory properties highlight its potential as a drug target.
- Galectin-1-specific inhibitors offer a rational strategy for cancer therapy, as mice lacking galectin-1 show no apparent abnormalities.
Purpose of the Study:
- To determine the X-ray crystallographic structure of human galectin-1.
- To facilitate structure-based design of novel galectin-1 inhibitors for cancer treatment.
Main Methods:
- Crystallization of human galectin-1 under six different conditions.
- Preliminary X-ray diffraction analysis of the generated crystals.
- Assignment of unit-cell parameters for successful crystal growth.
Main Results:
- Human galectin-1 crystals were successfully generated under multiple conditions.
- X-ray diffraction data yielded unit-cell parameters for two distinct crystal forms.
- One crystal form belongs to a tetragonal system, and the other is monoclinic P2(1).
Conclusions:
- The study reports two new crystal forms of human galectin-1.
- This structural information is crucial for the structure-based design of galectin-1 inhibitors.
- The findings support the development of targeted cancer therapies by inhibiting galectin-1.
